Indications,strategies,and development on prostate targeted biopsy:Report of the Panjiayuan Consensus Conference 2022
作者机构:Department of UrologyNational Cancer Center/National Clinical Research Center for Cancer/Cancer HospitalChinese Academy of Medical Sciences and Peking Union Medical CollegeBeijingChina Department of UrologyBeijing HospitalNational Center of GerontologyInstitute of Geriatric MedicineChinese Academy of Medical SciencesBeijingChina Department of RadiologyNational Cancer Center/National Clinical Research Center for Cancer/Cancer HospitalChinese Academy of Medical Sciences and Peking Union Medical CollegeBeijingChina Department of Nuclear Medicine(PET-CT Center)National Cancer Center/National Clinical Research Center for Cancer/Cancer HospitalChinese Academy of Medical Sciences and Peking Union Medical CollegeBeijingChina Department of UrologyThe Third Medical CenterChinese PLA General HospitalBeijingChina Department of UrologyInstitute of UrologyWest China HospitalSichuan UniversityChengduChina Department of UrologyBeijing Friendship HospitalCapital Medical UniversityBeijingChina Department of UrologyPeking Union Medical College HospitalChinese Academy of Medical Sciences and Peking Union Medical CollegeBeijingChina Eight-year Medical Doctor ProgramPeking Union Medical College HospitalChinese Academy of Medical Sciences and Peking Union Medical CollegeBeijingChina Department of UrologyUrology Research InstituteThe First Affiliated HospitalFujian Medical UniversityFuzhouChina Department of UrologyThe First Hospital of China Medical UniversityShenyangChina Department of UrologyShanxi Cancer HospitalAffiliated Cancer Hospital of Shanxi Medical UniversityTaiyuanChina Department of UrologyPeking University Third HospitalBeijingChina Department of UrologyThe First Affiliated HospitalZhejiang University School of MedicineHangzhouChina Department of UrologyShanghai Tenth People's HospitalTongji University School of MedicineShanghaiChina Department of UrologyChinese PLA General Hospital/PLA Medical SchoolBeijingChina Department of UrologyShanghai East HospitalSchool of MedicineTongji UniversityShanghaiChina Department of UrologyNanjing Drum Tower HospitalThe Affiliated Hospital of Nanjing University Medical SchoolNanjingChina Department of UrologyPeking University First HospitalBeijingChina Department of UrologyRenji HospitalSchool of MedicineShanghai Jiao Tong UniversityShanghaiChina Department of UrologyCancer CenterSun Yat-sen UniversityGuangzhouChina Department of UrologyTianjin Institute of UrologyThe Second Hospital of Tianjin Medical UniversityTianjinChina
出 版 物:《UroPrecision》 (精准泌尿学(英文))
年 卷 期:2023年第1卷第1期
页 面:3-19页
学科分类:1002[医学-临床医学] 100214[医学-肿瘤学] 10[医学]
基 金:Capital's Funds for Health Improvement and Research Grant/Award Number:2022-3-40714
主 题:image-guided biopsy magnetic resonance imaging prostatic neoplasms
摘 要:Prostate biopsy is the gold standard for diagnosing prostate cancer(PCa).Prostate targeted biopsy(TB)having a higher rate of detecting clinically significant PCa(csPCa)than traditional systematic biopsy(SB)is supported by high-quality ***,the TB indications and strategies are *** National Cancer Center/Cancer Hospital,Chinese Academy of Medical Sciences,invited a panel of recognized urology experts in PCa to address these topics at the Panjiayuan Consensus Conference *** conference results on prostate TB are presented *** National Cancer Center/Cancer Hospital,Chinese Academy of Medical Sciences identified 10 key areas of prostate biopsy:(1)selection of imaging examination;(2)indications of TB;(3)transperineal and transrectal prostate biopsy;(4)TB pathways;(5)TB and SB;(6)three techniques of TB;(7)the number of TB cores needed for one lesion;(8)core number for SB;(9)free-hand TB;(10)future development of TB/prostate ***,a panel of 25 recognized urologists and 2 radiologists from China were invited to attend this *** panel voted anonymously on 14 predetermined *** was based on the panelists clinical practice and opinion,rather than high-level *** voting outcomes were supported by the panel unequally,and details of the voting results were *** voting results can help clinicians to decide on biopsy timing and proper strategies,for which guidelines are *** also focused on the future development of TB and SB,such as the combined pathway of TB and SB,techniques of TB,biopsy cores,free-hand TB,and prostate-specific membrane antigen positron emission tomography/computed tomography.